Integer (NYSE:ITGR) PT Raised to $124.00 at Citigroup

Integer (NYSE:ITGR) had its target price boosted by Citigroup from $118.00 to $124.00 in a research report report published on Wednesday morning, Benzinga reports. Citigroup currently has a neutral rating on the medical equipment provider’s stock.

Other equities research analysts have also issued research reports about the stock. Benchmark restated a buy rating and set a $130.00 price target on shares of Integer in a research note on Friday, May 10th. CL King began coverage on Integer in a research note on Thursday, March 14th. They issued a buy rating and a $137.00 target price on the stock. Bank of America upgraded Integer from a neutral rating to a buy rating and increased their price target for the stock from $105.00 to $135.00 in a research note on Monday, April 15th. Truist Financial initiated coverage on Integer in a research note on Wednesday, May 15th. They issued a buy rating and a $137.00 price objective on the stock. Finally, KeyCorp increased their target price on shares of Integer from $123.00 to $139.00 and gave the stock an overweight rating in a research report on Tuesday, April 9th. Three equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of Moderate Buy and a consensus price target of $128.00.

Integer Stock Performance

Shares of ITGR opened at $122.63 on Wednesday. The stock has a 50 day moving average of $115.74 and a 200 day moving average of $105.18. The company has a current ratio of 3.32, a quick ratio of 2.01 and a debt-to-equity ratio of 0.76. Integer has a 12 month low of $69.40 and a 12 month high of $123.99. The company has a market capitalization of $4.11 billion, a price-to-earnings ratio of 42.43, a PEG ratio of 1.80 and a beta of 1.12.

Integer (NYSE:ITGR) last released its earnings results on Thursday, April 25th. The medical equipment provider reported $1.14 EPS for the quarter, topping analysts’ consensus estimates of $1.12 by $0.02. The company had revenue of $414.80 million for the quarter, compared to analysts’ expectations of $412.78 million. Integer had a return on equity of 11.25% and a net margin of 6.01%. The business’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same period in the previous year, the business posted $0.87 EPS. As a group, sell-side analysts forecast that Integer will post 5.27 earnings per share for the current year.

Insider Activity

In related news, SVP Andrew Senn sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $113.14, for a total transaction of $565,700.00. Following the completion of the transaction, the senior vice president now owns 4,658 shares of the company’s stock, valued at $527,006.12. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In other Integer news, EVP John A. Harris sold 312 shares of the firm’s stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $113.00, for a total value of $35,256.00. Following the sale, the executive vice president now owns 1,157 shares of the company’s stock, valued at approximately $130,741. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Andrew Senn sold 5,000 shares of the business’s stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $113.14, for a total value of $565,700.00. Following the transaction, the senior vice president now directly owns 4,658 shares of the company’s stock, valued at approximately $527,006.12. The disclosure for this sale can be found here. Insiders have sold a total of 6,812 shares of company stock worth $771,956 over the last ninety days. Company insiders own 2.00% of the company’s stock.

Institutional Investors Weigh In On Integer

Several hedge funds have recently bought and sold shares of the stock. Blue Trust Inc. increased its holdings in shares of Integer by 483.3% in the 4th quarter. Blue Trust Inc. now owns 455 shares of the medical equipment provider’s stock worth $45,000 after buying an additional 377 shares during the last quarter. Principal Securities Inc. purchased a new stake in Integer during the fourth quarter valued at about $67,000. Headlands Technologies LLC purchased a new stake in Integer during the first quarter valued at about $106,000. Van ECK Associates Corp lifted its stake in Integer by 22.0% during the third quarter. Van ECK Associates Corp now owns 1,733 shares of the medical equipment provider’s stock worth $136,000 after purchasing an additional 313 shares during the last quarter. Finally, Quadrant Capital Group LLC boosted its holdings in shares of Integer by 10.2% in the 4th quarter. Quadrant Capital Group LLC now owns 1,427 shares of the medical equipment provider’s stock worth $141,000 after purchasing an additional 132 shares in the last quarter. 99.29% of the stock is currently owned by institutional investors.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.